Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News
FDA grants MET inhibitor tepotinib accelerated approval for NSCLC
- Author:
- Sharon Worcester
Tepotinib is the first once-daily oral MET inhibitor approved for this patient population.
Article
COVID-19 vaccination in cancer patients: NCCN outlines priorities
- Author:
- Sharon Worcester
Recommended timing of vaccination varies based on cancer and treatment type.
News
Most common cancer diagnosis globally: Breast surpasses lung
- Author:
- Sharon Worcester
Breast cancer is now the most commonly diagnosed cancer worldwide, but lung cancer remains the leading overall...
News
Breast cancer survival disparities: Need to address obesity
- Author:
- Sharon Worcester
Higher rates of obesity and comorbidities in Black women with early breast cancer may explain the differences in...
News
VTE prophylaxis is feasible, effective in some high-risk cancer patients
- Author:
- Sharon Worcester
Risk scores can identify patients at high risk for VTE, and treatments that are effective and associated with...
News
Factor XI inhibitor–based anticoagulation strategies gain ground
- Author:
- Sharon Worcester
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”
News
Immunotherapy for ALL: Roles emerge in R/R disease, MRD+ disease
- Author:
- Sharon Worcester
“Another very exciting development is that these immunotherapies are now demonstrating efficacy and increased tolerability over chemotherapy in...
News
Beat AML: Precision medicine strategy feasible, superior to SOC for AML
- Author:
- Sharon Worcester
"The study is changing significantly the way we look at treating patients with AML, showing that precision medicine ... can improve short- and...
News
CAR T for all R/R DLBCL patients: The jury is still out
- Author:
- Sharon Worcester
The CAR T data are encouraging, but high-dose therapy and stem cell rescue may be just as good in chemosensitive...
News

Final ASCEND study data: Acalabrutinib beat standard of care for r/r CLL
- Author:
- Sharon Worcester
“Overall, these data support the use of acalabrutinib in patients with relapsed/refractory CLL, including...
News
Two-stage surgery to reduce ovarian cancer risk piques interest
- Author:
- Sharon Worcester
Women at high risk of developing ovarian cancer want to have options when it comes to taking steps such as...
News
Cancer disparities: One of the most pressing public health issues
- Author:
- Sharon Worcester
“The burden of cancer is not shouldered equally by all segments of the U.S. population,” the AACR states.
News
New data and trial outcomes clarify path to TFR in CML
- Author:
- Sharon Worcester
“I think it’s an important message that the [cardiovascular event] risk is there, at about the same rate, in the second 5 years.”
News
CML: New TKIs and combos show promise for resistant, intolerant disease
- Author:
- Sharon Worcester
“It is important that we have new therapeutic options to be able to help these patients who are going to be in...
News
Baseline gene expression predicts TKI response in CML
- Author:
- Sharon Worcester
The findings could inform clinical trials to investigate how to improve responses and to facilitate deep...